Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

CCCA may be caused by both hair traction and an immune response.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

TCDD changes skin cell growth and keratin production in mice.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Regulatory T cells are essential for normal and improved wound healing in mice.

Male-to-female skin grafts in mice are rejected due to sex-linked antigens.

HIV patients with lower CD4 T cell counts often have more skin problems.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Touch dome keratinocytes in adult skin have traits of different skin cell types.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

Blocking LFA-1 prevents hair loss in mice.

Blocking certain proteins on immune cells may help treat alopecia areata.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Lgr5+ stem cells do not cause skin tumors.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Certain NK cell changes in blood may indicate alopecia areata progression.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.